Sitemap | IBTROZI™ (taletrectinib)

This site is intended only for US healthcare professionals.

Sitemap

Home What is ROS1+ NSCLC?Efficacy

TKI-naïve
TKI-pretreated
Study design
Summary

Safety profile
Laboratory abnormalities
Dose modification rates
Onset and resolution
Summary

Recommended dosing
Dose reductions
Drug interactions
Dose modifications
Monitoring

Support and access

Patient support program
Distribution information

HCP resources
Patient and caregiver resources

NSCLC=non-small cell lung cancer; ROS1=ROS proto-oncogene 1; TKI=tyrosine kinase inhibitor.

Contact Us Contact Us

Privacy Notice Privacy Notice

Legal Statement Legal Statement

Sitemap Sitemap

Your Privacy Choices Your Privacy Choices

This product information is intended for US healthcare professionals only.

IBTROZI, the IBTROZI logo, NuvationConnect, Nuvation Bio, and the Nuvation Bio logo are trademarks of Nuvation Bio Inc.

© 2026 NUVATION BIO INC. ALL RIGHTS RESERVED. MAT-IBT-0044 06/2026